In the findings, CKIε was upregulated in AML and ALL patients compared to healthy individuals; thereby, it is possible to have the same oncogenic function as reported in other cancerous malignancies, showing its potential function as a biomarker in leukemia [91]. Here, CSNK1E is linked to leukemia.